Table 1 Clinical and selected laboratory findings among the SSc and control groups
|  | SSc group N = 72 | Control group N = 42 | P values |
|---|---|---|---|
SSc disease duration years (mean ± SD) | 6.9 ± 5.6 |  |  |
ANA | 79% | Â | Â |
Anti- SCL70 | 64% | Â | Â |
Anti-centromere | 29% | Â | Â |
Raynaud’s phenomena | 75% |  |  |
Digital ulcers | 31.9% | Â | Â |
Dyspnea and heart burn | 72.2% | Â | Â |
MRSS | 24.9 ± 9.3 |  |  |
ECG finding, normal | 45 (62.5%) | 42 (100%) | 0.009 |
Rt CCA atheroma | 30 (41.7%) | 0 (0%) | 0.001 |
Lt CCA atheroma | 30 (41.7%) | 0 (0%) | 0.001 |
Cr. clearance, normal | 66 (91.7%) | 42(100%) | 0.150 |
CRP; normal | 24 (33.3%) | 42(100%) | 0.000 |
Family history of CV disease, negative | 46 (64%) | 30 (71.4%) | 0.405 |
Brain diffusion MRI, positive | 0 (0%) | 0 (0%) | Â |
Brain FLAIR-MRI, hyperintense lesions | 25 (34.7%) | 0 (0%) | 0.004 |